'Design Therapeutics Inc (DSGN) Remains On Track For 2H Catalysts'; PT Raised at RBC Capital
Tweet Send to a Friend
RBC Capital analyst Leonid Timashev raised the price target on Design Therapeutics Inc (NASDAQ: DSGN) to $14.00 (from $13.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
